Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Genomic Health Inc

+ Add to Watchlist

G7H:GR

24.941 EUR 0.969 4.04%

As of 02:20:04 ET on 05/04/2015.

Snapshot for Genomic Health Inc (G7H)

Open: 23.853 Day's Range: 23.853 - 24.965 Volume: 0
Previous Close: 23.972 52wk Range: 17.505 - 31.843 1-Yr Rtn: +24.64%

Stock Chart for G7H

No chart data available.
  • G7H:GR 24.941
  • 1D
  • 1M
  • 1Y
23.972
Interactive G7H Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for G7H

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.6310
Est. PEG Ratio -
Market Cap (M EUR) 804.13
Shares Outstanding (M) 32.24
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for G7H

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for G7H

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.

Kimberly J Popovits "Kim"Chairman/President/CEOG Bradley ColeCFO/COO/Secretary
Steven ShakChief Scientific OfficerEmily FaucetteVP:Corporate Communications
More Company Profile & Key Executives for G7H

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil